Schedule 13G ownership disclosure

TRILLIUM THERAPEUTICS INC COM NEW

Security class unavailable · CUSIP: 89620X506

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
443,631
Percent of class
6.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-16-000965
Form type
SC 13G/A
Filer
Merlin BioMed Private Equity Advisors, L.L.C.
CIK
CIK 1429303
Filed
Feb 12, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub